Derek takes a look at the announcements from the PAX convention and the first wave of spoilers from Dragons of Tarkir.

Sylvain reviews his specs for this Modern season. In the light of changes in the Modern format, Pro Tour hype and expectations from players and speculators he analyses the different price trends in an attempt to improve his profit next Modern season.

Adam provides a complete matchup analysis and and sideboard guide for the most powerful deck in Standard–Abzan Midrange without Sylvan Caryatid.

The first season of PPTQ’s has just drawn to a close. Mike Lanigan looks at how the new system has compared to expectations, before covering some new developments in Standard.

Sigmund believes the MTG Market is moving higher, but don’t buy everything you can get hands on. This week he compares a couple options, highlighting why he likes some cards more than others despite their shared upward movement.

Adam explains how to beat the top-performing Modern archetypes from Pro Tour Fate Reforged!

Danny Brown goes over the major archetypes that dominated the Pro Tour in D.C., focusing on prices and reprint risk. If you’re looking for a (new) Modern deck to try out, this guide will help you assess the true costs involved.

Mike Lanigan pores over the results from Pro Tour Fate Reforged and discusses the state of the post-banning meta. Things are still pretty wide open, but that doesn’t mean certain strategies aren’t better positioned than others.

Check in with Matthew Lewis and Sylvain Lehoux for the weekly MTGO Market Report. This week they discuss the results of the Pro Tour and the initial reaction in online prices.

It’s easy to speculate liberally based on the results from last weekned’s Pro Tour, but there are reprint risks you need to be wary of. This week Sigmund recommends the cards with the best risk/reward equation coming out of the event.

Corbin Hosler looks at five specs he considers strong contenders right now, as we head into the Modern Pro Tour and the deployment of Fate Reforged on the big stage.